Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trial

MLA

MA Leone, et al. Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A Phase I Dose-Escalation Clinical Trial. Nov. 2022. EBSCOhost, https://doi.org/10.1101/2022.11.14.22282124.

APA

MA Leone, M Gelati, DC Profico, C Conti, C Spera, G Muzi, V Grespi, I Bicchi, C Ricciolini, D Ferrari, M Zarrelli, L Amoruso, G Placentino, P Crociani, F Apollo, P Di Viesti, D Fogli, T Popolizio, C Colosimo, … AL Vescovi. (2022). Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trial. https://doi.org/10.1101/2022.11.14.22282124

Chicago

MA Leone, M Gelati, DC Profico, C Conti, C Spera, G Muzi, V Grespi, et al. 2022. “Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A Phase I Dose-Escalation Clinical Trial,” November. doi:10.1101/2022.11.14.22282124.